Replies to post #130224 on $Pistol Pete$, $Mick$ & Friends Stock Picks /news,

[$Pistol Pete$]

$WEYL Daily and Weekly Chart

[$Pistol Pete$]

$GSAT Daily and Weekly Chart

[$Pistol Pete$]

$YIPI Daily and Weekly Chart

[$Pistol Pete$]

$SIPC Daily and Weekly Chart

[$Pistol Pete$]

$TRKG nice call

[$Pistol Pete$]

$WEYL Daily and Weekly Chart

[$Pistol Pete$]

$GSAT Daily and Weekly Chart

[$Pistol Pete$]

$YIPI Daily and Weekly Chart

[$Pistol Pete$]

$SIPC Daily and Weekly Chart

[$Pistol Pete$]

$PMCB Daily and Weekly Chart

[$Pistol Pete$]

$EBYH 6 Months Chart

[$Pistol Pete$]

$OMVS 6 Months Chart

[$Pistol Pete$]

$SSGOF 6 Months Chart

[$Pistol Pete$]

$NOXL 6 Months Chart

[$Pistol Pete$]

$EQLB 6 Months Chart

[$Pistol Pete$]

$LBRG 6 Months Chart

[$Pistol Pete$]

$WEYL 6 Months Chart

[$Pistol Pete$]

$SIPC 6 Months Chart

[$Pistol Pete$]

$ITKH 6 Months Chart

[$Pistol Pete$]

$YIPI 6 Months Chart

[$Pistol Pete$]

$GSAT 6 Months Chart

[$Pistol Pete$]

$ECOS 6 Months Chart

[$Pistol Pete$]

$MLGT 6 Months Chart

[$Pistol Pete$]

$TRKG 6 Months Chart

[$Pistol Pete$]

$TVOG 6 Months Chart

[$Pistol Pete$]

$FERN 6 Months Chart

[$Pistol Pete$]

$CNCT 6 Months Chart

[$Pistol Pete$]

$ITKH iTeknik Holding Corporation Reports 3Q FY17 Revenues of $499.3 Thousand and Net Income of $76.4 Thousand ITKH



May 2 3, 2017
OTC Disclosure & News Service

-

iTeknik Holding Corporation Reports 3Q FY17 Revenues of $499.3 Thousand and Net Income of $76.4 Thousand

WEST PALM BEACH, FL--(Marketwired - May 23, 2017) - iTeknik Holding Corporation (OTC PINK: ITKH) announced results for their third fiscal quarter ended March 31, 2017.

In the first operating quarter since acquiring the assets that are now operating as its Big Rhino Corporation subsidiary, iTeknik announced revenues of $499.3 thousand with net income of $76.4 thousand for the period.

Fred Wicks, iTeknik's Chairman and CEO said, "The results achieved by our Big Rhino Advertising Agency in our first operating quarter have been outstanding. Kyle Eng, President of Big Rhino, and his phenomenal team continue to produce bottom-line results that impress their automotive and non-automotive clients. Their hard work and dedication to quality are the reasons Big Rhino has already built a strong brand. We are adding new clients every month and as a result, have a solid and growing customer base."

Fred Wicks also said, "In addition to our strong financial results and business growth, we are making major strides in our long-term corporate strategy. We are diligently working on our audit that will allow us to eventually become fully reporting. We are also continuing our search for suitable acquisition and merger partners. We have hired an Investor Relations firm to help us get our message out to a wider community of investors using social media and other innovative tools. All of these efforts are dedicated to increasing the value of our stock for all of our shareholders."

iTeknik Holding Corporation (OTC PINK: ITKH) trades on the OTC Pink tier of the OTC Market For quotes and market information on the company, visit http://www.otcmarkets.com/stock/ITKH/company-info.

About iTeknik Holding Corporation:
iTeknik Holding Corporation's strategy (OTC PINK: ITKH) is to acquire fundamentally sound companies that are market accepted, scalable and demonstrate a quantifiable value proposition. Our focus is in companies that have strong market presence, brand awareness and talented and dedicated management teams. We seek companies with the potential to achieve exceptional performance over time in the Marketing, Advertising and Digital Media space and related technologies. iTeknik lends its operational support, management approach and financial resources to these companies to achieve improvements in revenue and earnings growth as well as positioning in the marketplace. iTeknik Holdings currently operates one wholly owned subsidiary, Big Rhino Corporation. For more information visit our website at www.iteknik.com.

About Big Rhino Corporation:
Big Rhino Corporation is a wholly owned subsidiary of iTeknik Holding Corporation and is a full-service advertising and digital media agency. Big Rhino excels in providing on-strategy, fast, precise and creative marketing solutions that get our clients BIG results. We maintain a nimble in-house creative team with a unique talent for delivering the highest quality creative that we believe is faster than anyone else. When combined with our completely integrated digital, interactive and media teams, our clients have access to a strategic and responsive advertising machine. For more information check us out at www.bigrhino.agency

Safe Harbor: This document contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.

Contact:

Investor Relations
Tom Nelson
[e-mail]
480-326-8577


Copyright © 2017 Marketwired. All Rights Reserved


The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

[$Pistol Pete$]

$EQLB check out this link and see EQLB in motion

http://investorshub.advfn.com/boards/msgsearch.aspx?searchstr=EQLB



Go $EQLB

[$Pistol Pete$]

$ITKH check out this link and see ITKH in motion

http://investorshub.advfn.com/boards/msgsearch.aspx?searchstr=ITKH



Go $ITKH

[$Pistol Pete$]

$ITKH iTeknik Holding Corporation Reports 3Q FY17 Revenues of $499.3 Thousand and Net Income of $76.4 Thousand ITKH



May 2 3, 2017
OTC Disclosure & News Service

-

iTeknik Holding Corporation Reports 3Q FY17 Revenues of $499.3 Thousand and Net Income of $76.4 Thousand

WEST PALM BEACH, FL--(Marketwired - May 23, 2017) - iTeknik Holding Corporation (OTC PINK: ITKH) announced results for their third fiscal quarter ended March 31, 2017.

In the first operating quarter since acquiring the assets that are now operating as its Big Rhino Corporation subsidiary, iTeknik announced revenues of $499.3 thousand with net income of $76.4 thousand for the period.

Fred Wicks, iTeknik's Chairman and CEO said, "The results achieved by our Big Rhino Advertising Agency in our first operating quarter have been outstanding. Kyle Eng, President of Big Rhino, and his phenomenal team continue to produce bottom-line results that impress their automotive and non-automotive clients. Their hard work and dedication to quality are the reasons Big Rhino has already built a strong brand. We are adding new clients every month and as a result, have a solid and growing customer base."

Fred Wicks also said, "In addition to our strong financial results and business growth, we are making major strides in our long-term corporate strategy. We are diligently working on our audit that will allow us to eventually become fully reporting. We are also continuing our search for suitable acquisition and merger partners. We have hired an Investor Relations firm to help us get our message out to a wider community of investors using social media and other innovative tools. All of these efforts are dedicated to increasing the value of our stock for all of our shareholders."

iTeknik Holding Corporation (OTC PINK: ITKH) trades on the OTC Pink tier of the OTC Market For quotes and market information on the company, visit http://www.otcmarkets.com/stock/ITKH/company-info.

About iTeknik Holding Corporation:
iTeknik Holding Corporation's strategy (OTC PINK: ITKH) is to acquire fundamentally sound companies that are market accepted, scalable and demonstrate a quantifiable value proposition. Our focus is in companies that have strong market presence, brand awareness and talented and dedicated management teams. We seek companies with the potential to achieve exceptional performance over time in the Marketing, Advertising and Digital Media space and related technologies. iTeknik lends its operational support, management approach and financial resources to these companies to achieve improvements in revenue and earnings growth as well as positioning in the marketplace. iTeknik Holdings currently operates one wholly owned subsidiary, Big Rhino Corporation. For more information visit our website at www.iteknik.com.

About Big Rhino Corporation:
Big Rhino Corporation is a wholly owned subsidiary of iTeknik Holding Corporation and is a full-service advertising and digital media agency. Big Rhino excels in providing on-strategy, fast, precise and creative marketing solutions that get our clients BIG results. We maintain a nimble in-house creative team with a unique talent for delivering the highest quality creative that we believe is faster than anyone else. When combined with our completely integrated digital, interactive and media teams, our clients have access to a strategic and responsive advertising machine. For more information check us out at www.bigrhino.agency

Safe Harbor: This document contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.

Contact:

Investor Relations
Tom Nelson
[e-mail]
480-326-8577


Copyright © 2017 Marketwired. All Rights Reserved


The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

[$Pistol Pete$]

$EBHY check out this link and see EBYH in motion

http://investorshub.advfn.com/boards/msgsearch.aspx?searchstr=EBYH



Go $EBYH

[$Pistol Pete$]

$OMVS check out this link and see OMVS in motion

http://investorshub.advfn.com/boards/msgsearch.aspx?searchstr=OMVS



Go $OMVS

[$Pistol Pete$]

$SSGOF check out this link and see SSGOF in motion

http://investorshub.advfn.com/boards/msgsearch.aspx?searchstr=SSGOF



Go $SSGOF

[$Pistol Pete$]

$NOXL check out this link and see NOXL in motion

http://investorshub.advfn.com/boards/msgsearch.aspx?searchstr=NOXL



Go $NOXL

[$Pistol Pete$]

$LBRG check out this link and see LBRG in motion

http://investorshub.advfn.com/boards/msgsearch.aspx?searchstr=LBRG



Go $LBRG

[$Pistol Pete$]

$FERN check out this link and see FERN in motion

http://investorshub.advfn.com/boards/msgsearch.aspx?searchstr=FERN



Go $FERN

[$Pistol Pete$]

$TVOG check out this link and see TVOG in motion

http://investorshub.advfn.com/boards/msgsearch.aspx?searchstr=TVOG



Go $TVOG

[$Pistol Pete$]

$PMCB PharmaCyte Biotech, Inc (OTCMKTS:PMCB) Continues to Work Toward IND Filing PMCB



The last time we touched upon PharmaCyte Biotech, Inc (OTCMKTS:PMCB) here at Street Register was back in March, when the company had no clear cut timeline for the filing process on its IND (Investigational New Drug) application for its upcoming clinical trial in locally advanced pancreatic cancer (LAPC).

While it’s still a fluid process with several boxes to tick in terms of preparing for the application and study, we did receive updates in the form of a company Q & A this week that could shed some light on the story. We always try to keep our readers abreast of any new press coming from the stocks we profile, so we want to pass along some snippets from the Q & A released by the company.

Sarah DeMare, the Product Development Champion with Facet Life Sciences and U.S. Agent for PharmaCyte Biotech, Inc (OTCMKTS:PMCB) was asked about several topics pertaining to the IND. Perhaps most importantly, she was asked to list off some of the items that are standing between PMCB and filing of the application.

“The single most important item PharmaCyte needed to learn from the FDA at the pre-IND meeting was the acceptability of PharmaCyte’s proposed cell line. Without that understanding, PharmaCyte was unable to move forward with the manufacture of its product candidate for the LAPC clinical trial.”

“An IND encompasses many things, dealing with the manufacture and characterization of the product candidate, the clinical study design and nonclinical studies. PharmaCyte’s therapy for pancreas cancer has undergone or been part of several studies, so incorporation of that information into the IND is not ‘rate limiting’ or ‘slowing down the progress towards submitting an IND.’ The clinical study design that PharmaCyte agreed to undertake after meeting with the FDA is currently being drafted. This is also not rate limiting. To conduct the clinical trial, PharmaCyte will need to manufacture, test and release a Master Cell Bank, a Working Cell Bank and the encapsulated live cells. This information is also required to be described and documented in detail in the IND. The manufacture of these items is the rate limiting factor involved in submitting the IND.”

“Before the IND is filed, the following items must be available for inclusion:

(a) Documentation of preclinical work done on the cells.
(b) Toxicology studies.
(c) Documentation of preclinical work done on the capsules themselves.
(d) A wide array of CMC (Chemistry, Manufacturing and Controls) documentation that verifies that the final biologic product (the encapsulated cells) has been produced under current Good Manufacturing Practices (cGMP)-compliant conditions.
(e) Labeling for the final investigational biologic product.
(f) Previous evidence of human experience with the pancreas cancer therapy (low-dose ifosfamide plus Cell-in-a-Box® encapsulated genetically modified human cells).
(h) The Investigator’s Brochure.
(i) The Informed Consent Form
(j) The Case Report Form”

(Source: Globe Newswire)

[$Pistol Pete$]

$YIPI Yippy, Inc. (YIPI) adds Former CIO of Halliburton (HAL) and Air Liquide S.A. to the Board of Directors YIPI

Jun 02, 2017
OTC Disclosure & News Service

-

Yippy, Inc. (YIPI) adds Former CIO of Halliburton (HAL) and Air Liquide S.A. to the Board of Directors

PR Newswire

ATLANTA, June 2, 2017

ATLANTA, June 2, 2017 /PRNewswire/ -- Yippy, Inc. (OTC MKTS: YIPI) (www.yippy.com) ("Yippy" or the "Company"), an enterprise unification company known for its Yippy EASE 360 platform, announced today that the Company's Board of Directors (the "Board") elected Arthur "Art" Huffman to serve as a director on the Board, fulfilling a previously vacant Board seat. Mr. Huffman had served as the Board's chief outside consultant since 2015.

Mr. Huffman is the principal and owner of A. Huffman Associates, LLC, an IT consulting and sourcing firm based in Houston, Texas. Previously, he served as the Chief Information Officer for Halliburton Company (HAL), the global oilfield services firm ("Halliburton"), where he was responsible for all aspects of its worldwide IT operations. Prior to joining Halliburton, Mr. Huffman held the same position at Air Liquide S.A., a multinational industrial gasses company based in Paris, France, where he maintained responsibility for the company's international IT operations. In addition to his technology background, Mr. Huffman has also held various executive management positions within Halliburton and Schlumberger Limited.

Mr. Huffman stated, "I've had the pleasure of working with Yippy for over two years, assisting with its data driven technologies, strategy and market penetration as a consultant. Now bringing my experience in-house, I hope to further assist the Company in achieving its goals and meeting the expectations of its shareholders. He continued, "I strongly believe in the search technology that we are bringing to market. The quality of the search based technology suite is second to none, and I believe our clients agree. Additionally, our Satellite Services Division is introducing technologies that present a real and disruptive force for satellite and terrestrial communications. The Company's tech, combined with its management and technical staff, provide a unique opportunity to create complete systems for highly secure access for our clients to Internet, personal and enterprise data, available worldwide through any network or combination of wireless technologies."

Richard Granville, Chairman and Chief Executive Officer of Yippy, commented, "Art will bring a wealth of knowledge and experience to the Board. Currently, we are engaged with many top global companies covering many verticals, including healthcare, aerospace, Internet, oil and gas, telecommunications and finance. Our solutions work horizontally across all verticals in any network configuration. We are proud and excited to have Art in our corner in an official capacity as we maintain our ambition to expand Yippy's global reach."

About Yippy, Inc.

Based in Atlanta, GA, Yippy, Inc. is a technology company that specializes in the development of search-based applications, data normalization, compression/optimization and aggregation through enterprise application service environments (EASE). Yippy's proprietary product suites are deployed to provide secure, redundant and maintained data services. The Company also provides the most advanced search appliance and is the best alternative for those seeking a replacement for the Google Search Appliance (GSA). The Company also operates several online Internet properties and educational reference portals. Investors can find current financial disclosure for the Company at http://www.otcmarkets.com/stock/YIPI/filings.

Forward-Looking Statements

The information contained herein includes "forward-looking statements." Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Additional information on risks and other factors that may affect the business and financial results of Yippy, Inc. can be found in the filings of Yippy, Inc. on OTC Markets (www.otcmarkets.com).

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/yippy-inc-yipi-adds-former-cio-of-halliburton-hal-and-air-liquide-sa-to-the-board-of-directors-300467730.html

SOURCE Yippy, Inc.


Copyright © 2017 PR Newswire. All Rights Reserved


The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

[$Pistol Pete$]

$EQLB Not an "Energy Drink" Last Shot is Nutritious EQLB

http://www.airgofandb.com/#about


Go $EQLB

[$Pistol Pete$]

$SIPC Daily and Weekly Charts

[$Pistol Pete$]

$ITKH 3 months chart

[$Pistol Pete$]

$TVOG Performance Report

http://www.barchart.com/detailedquote/stocks/TVOG

[$Pistol Pete$]

$EBYH Performance Report

http://www.barchart.com/detailedquote/stocks/EBYH

[$Pistol Pete$]

$OMVS Performance Report

http://www.barchart.com/detailedquote/stocks/OMVS

[$Pistol Pete$]

$SSGOF Performance Report

http://www.barchart.com/detailedquote/stocks/SSGOF

[$Pistol Pete$]

$NOXL Performance Report

http://www.barchart.com/detailedquote/stocks/NOXL

[$Pistol Pete$]

$LBRG Performance Report

http://www.barchart.com/detailedquote/stocks/LBRG

[$Pistol Pete$]

$ITKH Performance Report

http://www.barchart.com/detailedquote/stocks/ITKH

[$Pistol Pete$]

$ECOS Performance Report

http://www.barchart.com/detailedquote/stocks/ECOS

[$Pistol Pete$]

$OMVS Performance Report

http://www.barchart.com/detailedquote/stocks/OMVS

[$Pistol Pete$]

$PMCB PharmaCyte Biotech Updates Shareholders on ASCO Presentation to Oncologists PMCB



Jun 09, 2017
OTC Disclosure & News Service

-

LAGUNA HILLS, Calif., June 09, 2017 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today provided an update from the company’s meeting with leading clinical oncologists who are interested in participating in PharmaCyte’s planned pivotal clinical trial in locally advanced pancreas cancer (LAPC). The meeting was by invitation only during this year’s 53rd annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.

During the meeting, PharmaCyte’s Chief Executive Officer, Kenneth L. Waggoner, updated the attendees on the company’s efforts to advance its pancreas cancer therapy into a pivotal clinical trial. Dr. Matthias Löhr, the Chairman of PharmaCyte’s Medical and Scientific Advisory Board and the Principal Investigator for the two previous clinical trials using PharmaCyte’s pancreas cancer therapy, along with Dr. Ronald L. Korn, Founder and Chief Medical Officer of Imaging Endpoints, and Susan Tessmann, the Director of Clinical Operations at Translational Drug Development (TD2), made presentations on the progress that has been made and the path forward to the clinic. This was the first update since PharmaCyte’s pancreas cancer therapy was first introduced to a group of leading oncologists at last year’s annual meeting of ASCO. TD2 and Imaging Endpoints are the two major CROs who will be conducting the trial for PharmaCyte.

Commenting on the meeting, Mr. Waggoner said, “We were pleased to have had this unique opportunity to update the various stakeholders on the progress we have made in several aspects of our planned clinical trial. We are extremely grateful to the oncologists who attended the meeting, as well as the representatives from TD2 and Imaging Endpoints who participated in the meeting. We are particularly grateful to Dr. Matthias Löhr who travelled from Sweden to lead the discussion on the trial design and respond to questions posed by the oncologists.”

PharmaCyte continues to attract oncologists that are representatives of clinical trial sites and institutions that want to take part in the clinical trial. This year’s meeting was an opportunity to present PharmaCyte’s therapy for LAPC to the oncologists and to answer questions about the upcoming trial, the trial design, the clinical trial protocol and participation in the trial. These questions came from oncologists at major sites, known as “Hub” sites, and from related “Satellite” sites throughout the United States.

About PharmaCyte Biotech

PharmaCyte Biotech is a clinical stage biotechnology company developing cellular therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as “Cell-in-a-Box®.” This technology will be used as a platform upon which therapies for several types of cancer and diabetes are being developed.

PharmaCyte’s therapy for cancer involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active or “cancer-killing” form. These encapsulated cells are implanted as close to the patient’s cancerous tumor as possible. Once implanted, a chemotherapy drug that is normally activated in the liver (ifosfamide) is given intravenously at one-third the normal dose. The ifosfamide is carried by the circulatory system to where the encapsulated cells have been implanted. When the ifosfamide flows through the encapsulated cells, they act as a “bio-artificial liver” and activate the chemotherapy drug at the site of the cancer. This “targeted chemotherapy” has proven effective and safe to use in past clinical trials and results in no treatment related side effects.

PharmaCyte’s therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes involves encapsulating a human cell line that has been genetically engineered to produce, store and release insulin in response to the levels of blood sugar in the human body. The encapsulation will be done using the Cell-in-a-Box® technology. Once the encapsulated cells are implanted in a diabetic patient, they will function as a “bio-artificial pancreas” for purposes of insulin production.

Safe Harbor

This press release contains forward-looking statements, which are generally statements that are not historical facts. Forward-looking statements can be identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans," "will," "outlook" and similar expressions. Forward-looking statements are based on management's current plans, estimates, assumptions and projections, and speak only as of the date they are made. We undertake no obligation to update any forward-looking statement because of new information or future events, except as otherwise required by law. Forward-looking statements involve inherent risks and uncertainties, most of which are difficult to predict and are generally beyond our control. Actual results or outcomes may differ materially from those implied by the forward-looking statements due to the impact of numerous risk factors, many of which are discussed in more detail in our Annual Report on Form 10-K and our other reports filed with the Securities and Exchange Commission.

More information about PharmaCyte Biotech can be found at www.PharmaCyte.com. Information may also be obtained by contacting PharmaCyte’s Investor Relations Department.


Contact:

Investor Relations:
PharmaCyte Biotech, Inc.
Investor Relations Department
Telephone: [phone]
Email: [e-mail]

[$Pistol Pete$]

$EQLB Not an "Energy Drink" Last Shot is Nutritious EQLB

http://www.airgofandb.com/#about


Go $EQLB

[$Pistol Pete$]

$TVOG Turner Raises Guidance On Bitumen Shipping Acquisitions; Plans Expansion for Expected Infrastructure Boom

Jun 08, 2017
OTC Disclosure & News Service

-

Turner Raises Guidance On Bitumen Shipping Acquisitions; Plans Expansion for Expected Infrastructure Boom

Initial Bitumen Tanker Acquisitions are Projected to Generate $39,000,000 in Annual Revenue and $6,000,000 EBITDA.
PR Newswire

HOUSTON, June 8, 2017

HOUSTON, June 8, 2017 /PRNewswire/ -- Turner Valley Oil and Gas, Inc. (the "Company") (OTC: TVOG), pending name change to Turner Venture Group, Inc., has announced updated guidance estimates for its pending Bitumen Tanker asset acquisitions. The Company is currently progressing on schedule to complete the final due diligence and financing required for Closing.

Turner Venture Group

Based on increasing market demand, improved utilization, more complete fleet analysis, due diligence, and expectations to fully operate the fleet of five (5) Bitumen tanker vessels once acquired, the Company believes that it will generate over $39,000,000 in annual revenue and $6,000,000 in EBITDA. This estimate represents a significant increase from the Company's initial guidance. This does not take into account the planned expansion of the fleet and infrastructure, which will be discussed in detail in a future press release.

The Trump administration has pointed to a plan, using a mix of public and private funding along with tax incentives, that is meant to help spur $1 trillion in new spending on roads, bridges, and other construction during the next decade. Many fortune 500 companies such as John Deere and Martin Marietta are already spending $Billions ramping up production in anticipation of this. Turner is in the process of doing the same with this first acquisition, and upon a successful closing, the Company will be well positioned to leverage President Trump's widely publicized infrastructure proposal.

Adam Pashok, Managing Director of Network 1 Securities, Inc., reported "We are excited to complete these transactions using Turner as the foundational platform. The plan is to unlock asset value through strategic acquisitions and accelerate profitability through organic growth and expansion. Network 1 is very excited about this relationship with Turner. In addition, we will prepare for a senior listing application as soon as prudently possible."

Turner's management team has been working aggressively in the last few months to complete all of the critical steps that have been shared with our shareholders. This includes becoming fully SEC compliant, up-listing to the OTCQB, hiring a qualified CFO, and completing final compliance and required closing conditions to fully capitalize the Company for growth.

Existing shareholders and prospective investors can sign up to receive company news, announcements and investor updates at http://bitumentankers.com/signup/.

About Turner Valley Oil and Gas, Inc.

Turner Valley Oil and Gas, Inc. (pending name change to Turner Venture Group, Inc.) (OTC:TVOG) is a business holding company, with a historical focus on energy related holdings. The Company's acquisition model is focused on finding and evaluating profitable small to mid-sized businesses as acquisition candidates where cash flow can be improved through its buy, build & bolt-on model within the shipping, real assets, energy, infrastructure, enterprise technology, and manufacturing segments.

Certain statements in this press release are forward-looking and involve a number of risks and uncertainties. Such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended.



To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/turner-raises-guidance-on-bitumen-shipping-acquisitions-plans-expansion-for-expected-infrastructure-boom-300470864.html

SOURCE Turner Valley Oil and Gas, Inc.


Copyright © 2017 PR Newswire. All Rights Reserved


The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

[$Pistol Pete$]

$ITKH iTeknik Holding Corporation Reports 3Q FY17 Revenues of $499.3 Thousand and Net Income of $76.4 Thousand ITKH



May 2 3, 2017
OTC Disclosure & News Service

-

iTeknik Holding Corporation Reports 3Q FY17 Revenues of $499.3 Thousand and Net Income of $76.4 Thousand

WEST PALM BEACH, FL--(Marketwired - May 23, 2017) - iTeknik Holding Corporation (OTC PINK: ITKH) announced results for their third fiscal quarter ended March 31, 2017.

In the first operating quarter since acquiring the assets that are now operating as its Big Rhino Corporation subsidiary, iTeknik announced revenues of $499.3 thousand with net income of $76.4 thousand for the period.

Fred Wicks, iTeknik's Chairman and CEO said, "The results achieved by our Big Rhino Advertising Agency in our first operating quarter have been outstanding. Kyle Eng, President of Big Rhino, and his phenomenal team continue to produce bottom-line results that impress their automotive and non-automotive clients. Their hard work and dedication to quality are the reasons Big Rhino has already built a strong brand. We are adding new clients every month and as a result, have a solid and growing customer base."

Fred Wicks also said, "In addition to our strong financial results and business growth, we are making major strides in our long-term corporate strategy. We are diligently working on our audit that will allow us to eventually become fully reporting. We are also continuing our search for suitable acquisition and merger partners. We have hired an Investor Relations firm to help us get our message out to a wider community of investors using social media and other innovative tools. All of these efforts are dedicated to increasing the value of our stock for all of our shareholders."

iTeknik Holding Corporation (OTC PINK: ITKH) trades on the OTC Pink tier of the OTC Market For quotes and market information on the company, visit http://www.otcmarkets.com/stock/ITKH/company-info.

About iTeknik Holding Corporation:
iTeknik Holding Corporation's strategy (OTC PINK: ITKH) is to acquire fundamentally sound companies that are market accepted, scalable and demonstrate a quantifiable value proposition. Our focus is in companies that have strong market presence, brand awareness and talented and dedicated management teams. We seek companies with the potential to achieve exceptional performance over time in the Marketing, Advertising and Digital Media space and related technologies. iTeknik lends its operational support, management approach and financial resources to these companies to achieve improvements in revenue and earnings growth as well as positioning in the marketplace. iTeknik Holdings currently operates one wholly owned subsidiary, Big Rhino Corporation. For more information visit our website at www.iteknik.com.

About Big Rhino Corporation:
Big Rhino Corporation is a wholly owned subsidiary of iTeknik Holding Corporation and is a full-service advertising and digital media agency. Big Rhino excels in providing on-strategy, fast, precise and creative marketing solutions that get our clients BIG results. We maintain a nimble in-house creative team with a unique talent for delivering the highest quality creative that we believe is faster than anyone else. When combined with our completely integrated digital, interactive and media teams, our clients have access to a strategic and responsive advertising machine. For more information check us out at www.bigrhino.agency

Safe Harbor: This document contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.

Contact:

Investor Relations
Tom Nelson
[e-mail]
480-326-8577


Copyright © 2017 Marketwired. All Rights Reserved


The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

[$Pistol Pete$]

$EQLB Not an "Energy Drink" Last Shot is Nutritious EQLB

http://www.airgofandb.com/#about



Go $EQLB

[$Pistol Pete$]

$WFM Retail Stocks Slide in Wake of Amazon's Deal for Whole Foods

Source: Dow Jones News
By Riva Gold
Shares of retailers fell Friday after Amazon.com said it will buy Whole Foods Market, potentially squeezing its grocery store competitors.

It marked another hit to grocers that were already under pressure after Kroger, the nation's biggest supermarket chain, warned of disappointing earnings. Retailers from traditional grocers to big-box operators tumbled on fears that Amazon's plans to delve deeper into the grocery store space may hurt their businesses, similar to how the online retailer pressured bookstores.

"This is a shot across the bow," said Sean Lynch, co-head of global equities at the Wells Fargo Investment Institute. "The worry is that Amazon is going to impact the market, drive margins down."

Amazon said early Friday it would pay $42 a share for Whole Foods, valuing the grocer at a 27% premium to its closing price Thursday. The giant retailer's stock jumped 3.1%, while Whole Foods shares rose 27%.

Rival grocers Supervalu fell 14% and Kroger tumbled 13%. On Thursday Kroger dropped 19% after its said increasing competition will hurt earnings for the year.

Big-box operators such as Wal-Mart and Target fell 5.4% and 9.2%, respectively, on Friday.

Technology stocks also ticked lower, extending losses for a sector that has been under pressure over the past week.

The tech-heavy Nasdaq Composite fell 0.4%. The S&P 500 declined 0.2% and the Dow Jones Industrial Average lost 9.8 points, or less than 0.1%, to 21350.

Tech remains the best performing S&P 500 sector in the index in 2017, up 17% year-to-date. But the last week has been rough for the group. Since June 8, the sector tumbled about 3.9%. On Friday, the sector slipped 0.2%, on track for its third consecutive session of declines.

"Tech has done exceptionally well this year," said Yogi Dewan, chief executive at Hassium Asset Management, pointing to signs of solid revenue growth in the sector. "But at these valuations, we're not putting new money into it," he said.

Some of the biggest tech names have posted sharper declines. Since June 8, Apple's stock has tumbled 7.4%, while Google parent Alphabet is 5% lower.

Despite a wobble in some of this year's best performing stocks, equities posted their greatest weekly inflows this year, according to EPFR Global data. Mr. Dewan said pullbacks this year have been short and overall volatility has been low because of the high cash levels he's seen among investors, with many clients waiting for any pullbacks in the market to add to their stock holdings. Fund managers surveyed by Bank of America increased cash in their portfolios in June, bringing their cash allocations well above the historical average.

Government bond yields were slightly lower, with the yield on the 10-year Treasury note at 2.154% from 2.160%. Yields fall as prices rise.

The WSJ Dollar Index slipped 0.2% Friday after climbing significantly earlier this week after the Federal Reserve's Wednesday meeting, where officials signaled further interest rate rises ahead.

Write to Riva Gold at [e-mail]


(END) Dow Jones Newswires

June 16, 2017 12:13 ET (16:13 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.

[$Pistol Pete$]

$EQLB Daily and Weekly Ichimoku Chart





http://www.investopedia.com/walkthrough/forex/advanced/level7/ichimoku-cloud.aspx

[$Pistol Pete$]

$EBYH 3 Months Chart

[$Pistol Pete$]

$OMVS 3 Months Chart

[$Pistol Pete$]

$SSGOF 3 Months Chart

[$Pistol Pete$]

$NOXL 3 Months Chart

[Welcome2Pinkyland]

18 charts/ 18 reasons to trade:

1) $PDGO - possible reverse merger- news coming per company.


2) $OMVS - Merger/Acquisition play- Robotic Assistance Devices


3) $SSGOF - The #1 Vacation Rental and Homestay site in the Philippines! http://www.stopsleepgo.com/


4) $NOXL - Merger/Acquisition play - new CEO filed with the NVSOS
http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=mh%252fA3CxSHIBe2Dmd6ZhQQA%253d%253d&nt7=0


5) $EQLB - in 7-11 now. big distribution deal inked - equity partner Timbaland - national roll out of last shot© Energy drink.


6) $LBRG - 21m float. Chinese merger play


7) $WEYL - http://createappeuropa.com hot mobile app business. Millions in revenue and profit


8) $SIPC - Major Hemp play - and HEMP BEER http://sippindustries.com/


9) $ITKH - http://www.bigrhino.agency/


10) $YIPI - partnered up with GSAT who trades on NYSE -


11) $PMCB - Cell-in-a-Box® technology,


12) $GSAT- may partner with sprint


13) $ECOS recent 8k - $5m deal with big waste recycling company


14) $MLGT recent 8k - 24m float China merger. Company developing SNACHAT LIKE APP


15) $TVOG acquisition play http://bitumentankers.com/


16) $TRKG - reinstated/new directors/merger play


17) $CNCT -per 10q- On May 15, 2017, the Company established a Joint Venture Company


18) $EBYH - float 520k -primary focus - match medical marijuana users with the appropriate cannabis strains to treat their specific diseases or symptoms